Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TORCH trial of tranexamic acid for conservatively managed chronic subdural hematoma
NL-OMON60002Phase 4Recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tranexamic acid, sponsored by Amsterdam University Medical Center. Started Oct 2024; status: recruiting.
02
Drugs
tranexamic acid
Beyond the preview
Go deeper on NL-OMON60002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON60002.